Brief: HBM Healthcare Investments Says Everest Medicines Completed Its Announced IPO On Hong Kong Stock Exchange
Oct 9 (Reuters) - Everest Medicines Ltd 1952.HK :
* HBM HEALTHCARE INVESTMENTS - EVEREST MEDICINES, A
PRIVATELY HELD
CO IN PORTFOLIO OF HBM, COMPLETED ITS ANNOUNCED IPO ON HONG KONG
STOCK EXCHANGE
* HBM HEALTHCARE INVESTMENTS- EVEREST MEDICINES RAISED HKD
3.5
BILLION OF NEW CAPITAL THROUGH ISSUANCE OF 63.5 MILLION SHARES
AT PRICE OF HKD 55 PER SHARE
* HBM HEALTHCARE INVESTMENTS - HAS AN INDIRECT
PARTICIPATION IN
EVEREST MEDICINES OF SLIGHTLY MORE THAN CHF 4 MILLION THROUGH
C-BRIDGE CAPITAL IV FUND
Source text for Eikon: ID:nTENhvbdna
Further company coverage: 1952.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Everest Medicines
See all newsBrief: Everest Medicines Says NMPA Approves Cardamyst (Etripamil) NDA For PSVT In Adults In China
Brief: Everest Medicines Enters Commercialization Collaboration With Hainan Herui Pharmaceutical
Brief: Everest Medicines Says CBC Group Purchases 712,000 Everest Medicines Shares For Hk$19.2 Million From 16 To 17 June
Australia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region